Author

Andrew J. Wallace

Manchester Academic Health Science CentreORCID 0000-0002-9603-8892Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Andrew J. Wallace1 paper · University of California, Santa Cruz

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 3 Organism:human· 2 Research Focus:variant effect prediction· 2 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. Ansari· 2 shared A. Hadonou· 2 shared A. Kulkarni· 2 shared A. Ramsay Bowden· 2 shared A. Ross· 2 shared A. Taylor· 2 shared A.C. Hogg· 2 shared Adam C. ShawiD· 2 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

A. Ansari

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicineGenetics in MedicinePeer-reviewedSep 5, 2025

Quantifying evidence for phenotypic specificity (PP4) for syndromic phenotypes: Large-scale integration of rare germline FH variants from diagnostic laboratory testing for HLRCC (Hereditary Leiomyomatosis and Renal Cell Cancer) and renal cancer

Sophie Allen, Charlie F Rowlands, Samantha Butler…·Catarina Olimpio

The paper quantifies phenotypic specificity of rare FH variants in HLRCC and renal cancer using likelihood ratios from clinical and population data.

3 citations

humanwhole-exome sequencing

𝕏 PostBluesky

Genetic & Genomic MedicineGenetics in MedicinePeer-reviewedOct 24, 2024

Classification of Variants of Reduced Penetrance in High Penetrance Cancer Susceptibility Genes: Framework for Genetics Clinicians and Clinical Scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)

Alice Garrett, Sophie Allen, Miranda Durkie…·J. Williams

The paper develops a framework for classifying variants of reduced penetrance in cancer susceptibility genes to improve variant interpretation consistency.

17 citationstop 4%

statistical modelvariant effect prediction

𝕏 PostBluesky

GeneticsbioRxivPreprintJan 18, 2018

Inherited BRCA1 epimutation as a novel cause of breast and ovarian cancer

D. Gareth Evans, Elke Maria van Veen, Helen Byers…·William G. Newman

The paper identifies inherited BRCA1 promoter hypermethylation as a novel cause of breast and ovarian cancer in two families without germline BRCA1/2 pathogenic variants.

DOI 10.1101/246934

humanDNA methylation

𝕏 PostBluesky